Microsoft-G42 Deal Forces Huawei Exit, White House Hails Move 
LaMelo Ball’s Puma MB.03 Debuts in 'Team Bank' and 'Miami' Colorways 
Net zero is not just good science – it’s also a good deal for ordinary people 
Shein Confidently Pursues London IPO Amid U.S. Political and Regulatory Scrutiny 
Meet the ‘new consumer’: How shopper behaviour is changing in a post-inflation world 
Spare us the talk about a wages explosion. There’s nothing wrong with lifting Australia’s lowest wages in line with inflation 
Bronny James Chooses Nike LeBron 1s as Favorite, Talks About New LeBron Witness 8 
Space arms race may be underway 
Argentina Renews adidas Contract Until 2038 Ahead of 2024 Copa América Clash 
UK Human Rights Group Campaigns to Block Shein’s Potential London IPO 
Myth: How the US manipulates global markets for economic supremacy 
Starbucks Cuts Prices to Attract Customers Amid Inflation and Declining Traffic 
In some parts of Australia, local roads are falling apart. Here’s an easy federal fix 
Puma Challenges Nike and Adidas with Bold Move at Copa America 
McDonald’s Sparks Envy Among US Fans with New Canadian Fry Flavors: ‘Mad I’m Not in Canada’ 
Did the Victorians have better roads than us? A history of Britain’s potholed streets 
Illumina Inc., the DNA-sequencing giant, announced the resignation of CEO Francis deSouza and the interim appointment of Charles Dadswell, previously the firm's SVP and General Counsel. The unexpected departure is seen as a victory for activist investor Carl Icahn, who had been pushing for deSouza's removal.
Prior to his appointment, Dadswell served as the senior vice president and general counsel at Illumina Inc. DeSouza's resignation was seen as a victory for activist investor Carl Icahn as he has been trying to remove the CEO from the DNA-sequencing firm.
As per Fortune, the outgoing chief survived Icahn's attacks on him after he was re-elected to the company's board late last month. He was among the eight executives to have earned a spot on the board, and the American financier was apparently against it.
The 87-year-old activist investor was said to have started pushing for board seats as early as March and criticized Illumina's board and management for selling and then buying back Grail Inc. later at a higher price. He also lambastes the company for pushing through with the deal even if the regulators in Europe opposed it.
Now, weeks after Icahn's failure to oust DeSouza, Illumina confirmed on Sunday, June 11, that its board of directors received the CEO's resignation, and they have accepted it. The company also released a statement for his departure and revealed its transition plans as well.
"We thank Francis for his contributions and leadership, and are very excited about embarking on the next chapter of Illumina's great journey," Illumina's chairman of the board, Stephen P. MacMillan, said in a press release. "Illumina's technology remains at the forefront of DNA sequencing and has continued to set the pace for the industry. We are confident Illumina can continue to execute on its goals while we conduct and complete a CEO search process."
Finally, Illumina said that as part of its transition plans, it is now looking for an executive who will permanently take over the role of CEO. The search will include both internal and external candidates. While DeSouza's resignation is already in effect, he will stay in the company as an adviser until July 31.
Photo by: Illumina/Wikimedia Commons(Public Domain)
_logo.jpg){kind=link}